Financial Information for the Company and Its Subsidiaries (Tables)
|
12 Months Ended |
Dec. 31, 2016 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
Summary of Condensed Consolidating Balance Sheets |
Acadia Healthcare Company, Inc.
Condensed Consolidating Balance Sheets
December 31, 2016
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
— |
|
|
$ |
15,681 |
|
|
$ |
41,382 |
|
|
$ |
— |
|
|
$ |
57,063 |
|
Accounts receivable, net
|
|
|
— |
|
|
|
209,124 |
|
|
|
54,203 |
|
|
|
— |
|
|
|
263,327 |
|
Other current assets
|
|
|
— |
|
|
|
61,724 |
|
|
|
45,813 |
|
|
|
— |
|
|
|
107,537 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
— |
|
|
|
286,529 |
|
|
|
141,398 |
|
|
|
— |
|
|
|
427,927 |
|
Property and equipment, net
|
|
|
— |
|
|
|
940,880 |
|
|
|
1,762,815 |
|
|
|
— |
|
|
|
2,703,695 |
|
Goodwill
|
|
|
— |
|
|
|
1,935,260 |
|
|
|
745,928 |
|
|
|
— |
|
|
|
2,681,188 |
|
Intangible assets, net
|
|
|
— |
|
|
|
56,676 |
|
|
|
26,634 |
|
|
|
— |
|
|
|
83,310 |
|
Deferred tax assets – noncurrent
|
|
|
13,522 |
|
|
|
— |
|
|
|
4,606 |
|
|
|
(14,348 |
) |
|
|
3,780 |
|
Derivative instruments
|
|
|
73,509 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
73,509 |
|
Investment in subsidiaries
|
|
|
4,885,865 |
|
|
|
— |
|
|
|
— |
|
|
|
(4,885,865 |
) |
|
|
— |
|
Other assets
|
|
|
493,294 |
|
|
|
40,480 |
|
|
|
7,189 |
|
|
|
(489,646 |
) |
|
|
51,317 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
5,466,190 |
|
|
$ |
3,259,825 |
|
|
$ |
2,688,570 |
|
|
$ |
(5,389,859 |
) |
|
$ |
6,024,726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current portion of long-term debt
|
|
$ |
34,550 |
|
|
$ |
— |
|
|
$ |
255 |
|
|
$ |
— |
|
|
$ |
34,805 |
|
Accounts payable
|
|
|
— |
|
|
|
49,205 |
|
|
|
30,829 |
|
|
|
— |
|
|
|
80,034 |
|
Accrued salaries and benefits
|
|
|
— |
|
|
|
72,835 |
|
|
|
32,233 |
|
|
|
— |
|
|
|
105,068 |
|
Other accrued liabilities
|
|
|
33,616 |
|
|
|
24,375 |
|
|
|
64,967 |
|
|
|
— |
|
|
|
122,958 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
68,166 |
|
|
|
146,415 |
|
|
|
128,284 |
|
|
|
— |
|
|
|
342,865 |
|
Long-term debt
|
|
|
3,230,300 |
|
|
|
— |
|
|
|
512,350 |
|
|
|
(489,646 |
) |
|
|
3,253,004 |
|
Deferred tax liabilities – noncurrent
|
|
|
— |
|
|
|
40,574 |
|
|
|
52,294 |
|
|
|
(14,348 |
) |
|
|
78,520 |
|
Other liabilities
|
|
|
— |
|
|
|
101,938 |
|
|
|
62,921 |
|
|
|
— |
|
|
|
164,859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
3,298,466 |
|
|
|
288,927 |
|
|
|
755,849 |
|
|
|
(503,994 |
) |
|
|
3,839,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
17,754 |
|
|
|
— |
|
|
|
17,754 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
2,167,724 |
|
|
|
2,970,898 |
|
|
|
1,914,967 |
|
|
|
(4,885,865 |
) |
|
|
2,167,724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
$ |
5,466,190 |
|
|
$ |
3,259,825 |
|
|
$ |
2,688,570 |
|
|
$ |
(5,389,859 |
) |
|
$ |
6,024,726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acadia Healthcare Company, Inc.
Condensed Consolidating Balance Sheets
December 31, 2015
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
— |
|
|
$ |
1,987 |
|
|
$ |
9,228 |
|
|
$ |
— |
|
|
$ |
11,215 |
|
Accounts receivable, net
|
|
|
— |
|
|
|
187,546 |
|
|
|
29,080 |
|
|
|
— |
|
|
|
216,626 |
|
Other current assets
|
|
|
— |
|
|
|
57,968 |
|
|
|
8,927 |
|
|
|
— |
|
|
|
66,895 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
— |
|
|
|
247,501 |
|
|
|
47,235 |
|
|
|
— |
|
|
|
294,736 |
|
Property and equipment, net
|
|
|
— |
|
|
|
805,439 |
|
|
|
903,614 |
|
|
|
— |
|
|
|
1,709,053 |
|
Goodwill
|
|
|
— |
|
|
|
1,835,339 |
|
|
|
292,876 |
|
|
|
— |
|
|
|
2,128,215 |
|
Intangible assets, net
|
|
|
— |
|
|
|
57,024 |
|
|
|
2,551 |
|
|
|
— |
|
|
|
59,575 |
|
Deferred tax assets – noncurrent
|
|
|
3,946 |
|
|
|
40,587 |
|
|
|
4,581 |
|
|
|
— |
|
|
|
49,114 |
|
Investment in subsidiaries
|
|
|
3,495,067 |
|
|
|
— |
|
|
|
— |
|
|
|
(3,495,067 |
) |
|
|
— |
|
Other assets
|
|
|
427,270 |
|
|
|
32,947 |
|
|
|
2,322 |
|
|
|
(424,024 |
) |
|
|
38,515 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
3,926,283 |
|
|
$ |
3,018,837 |
|
|
$ |
1,253,179 |
|
|
$ |
(3,919,091 |
) |
|
$ |
4,279,208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current portion of long-term debt
|
|
$ |
45,125 |
|
|
$ |
— |
|
|
$ |
235 |
|
|
$ |
— |
|
|
$ |
45,360 |
|
Accounts payable
|
|
|
— |
|
|
|
75,015 |
|
|
|
16,326 |
|
|
|
— |
|
|
|
91,341 |
|
Accrued salaries and benefits
|
|
|
— |
|
|
|
66,249 |
|
|
|
14,447 |
|
|
|
— |
|
|
|
80,696 |
|
Other accrued liabilities
|
|
|
26,132 |
|
|
|
10,886 |
|
|
|
35,788 |
|
|
|
— |
|
|
|
72,806 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
71,257 |
|
|
|
152,150 |
|
|
|
66,796 |
|
|
|
— |
|
|
|
290,203 |
|
Long-term debt
|
|
|
2,171,998 |
|
|
|
— |
|
|
|
447,410 |
|
|
|
(424,024 |
) |
|
|
2,195,384 |
|
Deferred tax liabilities – noncurrent
|
|
|
— |
|
|
|
— |
|
|
|
23,936 |
|
|
|
— |
|
|
|
23,936 |
|
Other liabilities
|
|
|
— |
|
|
|
75,159 |
|
|
|
3,443 |
|
|
|
— |
|
|
|
78,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
2,243,255 |
|
|
|
227,309 |
|
|
|
541,585 |
|
|
|
(424,024 |
) |
|
|
2,588,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
8,055 |
|
|
|
— |
|
|
|
8,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
1,683,028 |
|
|
|
2,791,528 |
|
|
|
703,539 |
|
|
|
(3,495,067 |
) |
|
|
1,683,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
$ |
3,926,283 |
|
|
$ |
3,018,837 |
|
|
$ |
1,253,179 |
|
|
$ |
(3,919,091 |
) |
|
$ |
4,279,208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Condensed Consolidating Statement of Comprehensive Income |
Acadia Healthcare Company, Inc.
Condensed Consolidating Statement of
Comprehensive Income
Year Ended December 31, 2016
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Revenue before provision for doubtful accounts
|
|
$ |
— |
|
|
$ |
1,662,734 |
|
|
$ |
1,190,089 |
|
|
$ |
— |
|
|
$ |
2,852,823 |
|
Provision for doubtful accounts
|
|
|
— |
|
|
|
(38,349 |
) |
|
|
(3,560 |
) |
|
|
— |
|
|
|
(41,909 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
— |
|
|
|
1,624,385 |
|
|
|
1,186,529 |
|
|
|
— |
|
|
|
2,810,914 |
|
Salaries, wages and benefits
|
|
|
28,345 |
|
|
|
865,104 |
|
|
|
648,405 |
|
|
|
— |
|
|
|
1,541,854 |
|
Professional fees
|
|
|
— |
|
|
|
89,062 |
|
|
|
96,424 |
|
|
|
— |
|
|
|
185,486 |
|
Supplies
|
|
|
— |
|
|
|
76,246 |
|
|
|
41,179 |
|
|
|
— |
|
|
|
117,425 |
|
Rents and leases
|
|
|
— |
|
|
|
34,540 |
|
|
|
38,808 |
|
|
|
— |
|
|
|
73,348 |
|
Other operating expenses
|
|
|
— |
|
|
|
206,308 |
|
|
|
106,248 |
|
|
|
— |
|
|
|
312,556 |
|
Depreciation and amortization
|
|
|
— |
|
|
|
58,018 |
|
|
|
77,085 |
|
|
|
— |
|
|
|
135,103 |
|
Interest expense, net
|
|
|
50,921 |
|
|
|
75,848 |
|
|
|
54,556 |
|
|
|
— |
|
|
|
181,325 |
|
Debt extinguishment costs
|
|
|
4,253 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,253 |
|
Loss on divestiture
|
|
|
— |
|
|
|
778 |
|
|
|
178,031 |
|
|
|
— |
|
|
|
178,809 |
|
Gain on foreign currency derivatives
|
|
|
(523 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(523 |
) |
Transaction-related expenses
|
|
|
— |
|
|
|
32,173 |
|
|
|
16,150 |
|
|
|
— |
|
|
|
48,323 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
82,996 |
|
|
|
1,438,077 |
|
|
|
1,256,886 |
|
|
|
— |
|
|
|
2,777,959 |
|
(Loss) income from continuing operations before income taxes
|
|
|
(82,996 |
) |
|
|
186,308 |
|
|
|
(70,357 |
) |
|
|
— |
|
|
|
32,955 |
|
Equity in earnings of subsidiaries
|
|
|
65,560 |
|
|
|
— |
|
|
|
— |
|
|
|
(65,560 |
) |
|
|
— |
|
(Benefit from) provision for income taxes
|
|
|
(21,612 |
) |
|
|
68,335 |
|
|
|
(17,944 |
) |
|
|
— |
|
|
|
28,779 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
4,176 |
|
|
|
117,973 |
|
|
|
(52,413 |
) |
|
|
(65,560 |
) |
|
|
4,176 |
|
Income from discontinued operations, net of income taxes
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
4,176 |
|
|
|
117,973 |
|
|
|
(52,413 |
) |
|
|
(65,560 |
) |
|
|
4,176 |
|
Net loss attributable to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
1,967 |
|
|
|
— |
|
|
|
1,967 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Acadia Healthcare Company, Inc.
|
|
$ |
4,176 |
|
|
$ |
117,973 |
|
|
$ |
(50,446 |
) |
|
$ |
(65,560 |
) |
|
$ |
6,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation gain
|
|
|
— |
|
|
|
— |
|
|
|
(477,772 |
) |
|
|
— |
|
|
|
(477,772 |
) |
Gain on derivative instruments
|
|
|
40,598 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
40,598 |
|
Pension liability adjustment, net
|
|
|
— |
|
|
|
— |
|
|
|
(7,749 |
) |
|
|
— |
|
|
|
(7,749 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income
|
|
|
40,598 |
|
|
|
— |
|
|
|
(485,521 |
) |
|
|
— |
|
|
|
(444,923 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
$ |
44,774 |
|
|
$ |
117,973 |
|
|
$ |
(535,967 |
) |
|
$ |
(65,560 |
) |
|
$ |
(438,780 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acadia Healthcare Company, Inc.
Condensed Consolidating Statement of
Comprehensive Income
Year Ended December 31, 2015
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Revenue before provision for doubtful accounts
|
|
$ |
— |
|
|
$ |
1,415,016 |
|
|
$ |
414,603 |
|
|
$ |
— |
|
|
$ |
1,829,619 |
|
Provision for doubtful accounts
|
|
|
— |
|
|
|
(32,614 |
) |
|
|
(2,513 |
) |
|
|
— |
|
|
|
(35,127 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
— |
|
|
|
1,382,402 |
|
|
|
412,090 |
|
|
|
— |
|
|
|
1,794,492 |
|
Salaries, wages and benefits
|
|
|
20,472 |
|
|
|
726,215 |
|
|
|
227,045 |
|
|
|
— |
|
|
|
973,732 |
|
Professional fees
|
|
|
— |
|
|
|
83,422 |
|
|
|
33,041 |
|
|
|
— |
|
|
|
116,463 |
|
Supplies
|
|
|
— |
|
|
|
65,077 |
|
|
|
15,586 |
|
|
|
— |
|
|
|
80,663 |
|
Rents and leases
|
|
|
— |
|
|
|
29,094 |
|
|
|
3,434 |
|
|
|
— |
|
|
|
32,528 |
|
Other operating expenses
|
|
|
— |
|
|
|
170,018 |
|
|
|
36,728 |
|
|
|
— |
|
|
|
206,746 |
|
Depreciation and amortization
|
|
|
— |
|
|
|
41,768 |
|
|
|
21,782 |
|
|
|
— |
|
|
|
63,550 |
|
Interest expense, net
|
|
|
68,533 |
|
|
|
17,476 |
|
|
|
20,733 |
|
|
|
— |
|
|
|
106,742 |
|
Debt extinguishment costs
|
|
|
10,818 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10,818 |
|
Loss on foreign currency derivatives
|
|
|
1,926 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,926 |
|
Transaction-related expenses
|
|
|
— |
|
|
|
24,914 |
|
|
|
11,657 |
|
|
|
— |
|
|
|
36,571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
101,749 |
|
|
|
1,157,984 |
|
|
|
370,006 |
|
|
|
— |
|
|
|
1,629,739 |
|
(Loss) income from continuing operations before income taxes
|
|
|
(101,749 |
) |
|
|
224,418 |
|
|
|
42,084 |
|
|
|
— |
|
|
|
164,753 |
|
Equity in earnings of subsidiaries
|
|
|
176,178 |
|
|
|
— |
|
|
|
— |
|
|
|
(176,178 |
) |
|
|
— |
|
(Benefit from) provision for income taxes
|
|
|
(37,047 |
) |
|
|
85,765 |
|
|
|
4,670 |
|
|
|
— |
|
|
|
53,388 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
111,476 |
|
|
|
138,653 |
|
|
|
37,414 |
|
|
|
(176,178 |
) |
|
|
111,365 |
|
Income from discontinued operations, net of income taxes
|
|
|
— |
|
|
|
111 |
|
|
|
— |
|
|
|
— |
|
|
|
111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
111,476 |
|
|
|
138,764 |
|
|
|
37,414 |
|
|
|
(176,178 |
) |
|
|
111,476 |
|
Net loss attributable to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
1,078 |
|
|
|
— |
|
|
|
1,078 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Acadia Healthcare Company, Inc.
|
|
$ |
111,476 |
|
|
$ |
138,764 |
|
|
$ |
38,492 |
|
|
$ |
(176,178 |
) |
|
$ |
112,554 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation gain
|
|
|
— |
|
|
|
— |
|
|
|
(40,103 |
) |
|
|
— |
|
|
|
(40,103 |
) |
Pension liability adjustment, net
|
|
|
— |
|
|
|
— |
|
|
|
3,826 |
|
|
|
— |
|
|
|
3,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income
|
|
|
— |
|
|
|
— |
|
|
|
(36,277 |
) |
|
|
— |
|
|
|
(36,277 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
$ |
111,476 |
|
|
$ |
138,764 |
|
|
$ |
2,215 |
|
|
$ |
(176,178 |
) |
|
$ |
76,277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acadia Healthcare Company, Inc.
Condensed Consolidating Statement of
Comprehensive Income
Year Ended December 31, 2014
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Revenue before provision for doubtful accounts
|
|
$ |
— |
|
|
$ |
826,465 |
|
|
$ |
204,319 |
|
|
$ |
— |
|
|
$ |
1,030,784 |
|
Provision for doubtful accounts
|
|
|
— |
|
|
|
(23,866 |
) |
|
|
(2,317 |
) |
|
|
— |
|
|
|
(26,183 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
— |
|
|
|
802,599 |
|
|
|
202,002 |
|
|
|
— |
|
|
|
1,004,601 |
|
Salaries, wages and benefits
|
|
|
10,058 |
|
|
|
459,297 |
|
|
|
106,057 |
|
|
|
— |
|
|
|
575,412 |
|
Professional fees
|
|
|
— |
|
|
|
38,632 |
|
|
|
13,850 |
|
|
|
— |
|
|
|
52,482 |
|
Supplies
|
|
|
— |
|
|
|
40,511 |
|
|
|
7,911 |
|
|
|
— |
|
|
|
48,422 |
|
Rents and leases
|
|
|
— |
|
|
|
10,136 |
|
|
|
2,065 |
|
|
|
— |
|
|
|
12,201 |
|
Other operating expenses
|
|
|
— |
|
|
|
83,835 |
|
|
|
26,819 |
|
|
|
— |
|
|
|
110,654 |
|
Depreciation and amortization
|
|
|
— |
|
|
|
22,990 |
|
|
|
9,677 |
|
|
|
— |
|
|
|
32,667 |
|
Interest expense, net
|
|
|
27,199 |
|
|
|
6,207 |
|
|
|
14,815 |
|
|
|
— |
|
|
|
48,221 |
|
Gain on foreign currency derivatives
|
|
|
(15,262 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(15,262 |
) |
Transaction-related expenses
|
|
|
— |
|
|
|
12,367 |
|
|
|
1,283 |
|
|
|
— |
|
|
|
13,650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
21,995 |
|
|
|
673,975 |
|
|
|
182,477 |
|
|
|
— |
|
|
|
878,447 |
|
(Loss) income from continuing operations before income taxes
|
|
|
(21,995 |
) |
|
|
128,624 |
|
|
|
19,525 |
|
|
|
— |
|
|
|
126,154 |
|
Equity in earnings of subsidiaries
|
|
|
97,414 |
|
|
|
— |
|
|
|
— |
|
|
|
(97,414 |
) |
|
|
— |
|
(Benefit from) provision for income taxes
|
|
|
(7,621 |
) |
|
|
44,608 |
|
|
|
5,935 |
|
|
|
— |
|
|
|
42,922 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
83,040 |
|
|
|
84,016 |
|
|
|
13,590 |
|
|
|
(97,414 |
) |
|
|
83,232 |
|
Loss from discontinued operations, net of income taxes
|
|
|
— |
|
|
|
(192 |
) |
|
|
— |
|
|
|
— |
|
|
|
(192 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
83,040 |
|
|
$ |
83,824 |
|
|
$ |
13,590 |
|
|
$ |
(97,414 |
) |
|
$ |
83,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation loss
|
|
|
— |
|
|
|
— |
|
|
|
(66,206 |
) |
|
|
— |
|
|
|
(66,206 |
) |
Pension liability adjustment, net
|
|
|
— |
|
|
|
— |
|
|
|
(2,164 |
) |
|
|
— |
|
|
|
(2,164 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss
|
|
|
— |
|
|
|
— |
|
|
|
(68,370 |
) |
|
|
— |
|
|
|
(68,370 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
$ |
83,040 |
|
|
$ |
83,824 |
|
|
$ |
(54,780 |
) |
|
$ |
(97,414 |
) |
|
$ |
14,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Condensed Consolidating Statement of Cash Flows |
Acadia Healthcare Company, Inc.
Condensed Consolidating Statement of Cash
Flows
Year Ended December 31, 2016
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
4,176 |
|
|
$ |
117,973 |
|
|
$ |
(52,413 |
) |
|
$ |
(65,560 |
) |
|
$ |
4,176 |
|
Adjustments to reconcile net income (loss) to net cash (used in)
provided by continuing operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in earnings of subsidiaries
|
|
|
(65,560 |
) |
|
|
— |
|
|
|
— |
|
|
|
65,560 |
|
|
|
— |
|
Depreciation and amortization
|
|
|
— |
|
|
|
58,018 |
|
|
|
77,085 |
|
|
|
— |
|
|
|
135,103 |
|
Amortization of debt issuance costs
|
|
|
10,751 |
|
|
|
— |
|
|
|
(427 |
) |
|
|
— |
|
|
|
10,324 |
|
Equity-based compensation expense
|
|
|
28,345 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
28,345 |
|
Deferred income tax (benefit) expense
|
|
|
(2,172 |
) |
|
|
50,611 |
|
|
|
(19,792 |
) |
|
|
— |
|
|
|
28,647 |
|
Loss from discontinued operations, net of taxes
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Debt extinguishment costs
|
|
|
4,253 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,253 |
|
Loss on divestiture
|
|
|
— |
|
|
|
778 |
|
|
|
178,031 |
|
|
|
— |
|
|
|
178,809 |
|
(Gain) loss on foreign currency derivatives
|
|
|
(523 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(523 |
) |
Other
|
|
|
— |
|
|
|
4,022 |
|
|
|
693 |
|
|
|
— |
|
|
|
4,715 |
|
Change in operating assets and liabilities, net of effect of
acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
— |
|
|
|
(24,017 |
) |
|
|
8,299 |
|
|
|
— |
|
|
|
(15,718 |
) |
Other current assets
|
|
|
— |
|
|
|
(3,138 |
) |
|
|
(17,510 |
) |
|
|
— |
|
|
|
(20,648 |
) |
Other assets
|
|
|
(3,109 |
) |
|
|
(4,048 |
) |
|
|
(306 |
) |
|
|
3,109 |
|
|
|
(4,354 |
) |
Accounts payable and other accrued liabilities
|
|
|
— |
|
|
|
(45,552 |
) |
|
|
68,245 |
|
|
|
— |
|
|
|
22,693 |
|
Accrued salaries and benefits
|
|
|
— |
|
|
|
3,844 |
|
|
|
(12,416 |
) |
|
|
— |
|
|
|
(8,572 |
) |
Other liabilities
|
|
|
— |
|
|
|
4,050 |
|
|
|
434 |
|
|
|
— |
|
|
|
4,484 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by continuing operating activities
|
|
|
(23,839 |
) |
|
|
162,541 |
|
|
|
229,923 |
|
|
|
3,109 |
|
|
|
371,734 |
|
Net cash used in discontinued operating activities
|
|
|
— |
|
|
|
(10,256 |
) |
|
|
— |
|
|
|
— |
|
|
|
(10,256 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by operating activities
|
|
|
(23,839 |
) |
|
|
152,285 |
|
|
|
229,923 |
|
|
|
3,109 |
|
|
|
361,478 |
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for acquisitions, net of cash acquired
|
|
|
— |
|
|
|
(103,359 |
) |
|
|
(580,096 |
) |
|
|
— |
|
|
|
(683,455 |
) |
Cash paid for capital expenditures
|
|
|
— |
|
|
|
(177,593 |
) |
|
|
(129,879 |
) |
|
|
— |
|
|
|
(307,472 |
) |
Cash paid for real estate acquisitions
|
|
|
— |
|
|
|
(28,956 |
) |
|
|
(11,801 |
) |
|
|
— |
|
|
|
(40,757 |
) |
Settlement of foreign currency derivatives
|
|
|
— |
|
|
|
523 |
|
|
|
— |
|
|
|
— |
|
|
|
523 |
|
Cash received for divestiture
|
|
|
370,000 |
|
|
|
7,859 |
|
|
|
(4,593 |
) |
|
|
— |
|
|
|
373,266 |
|
Other
|
|
|
— |
|
|
|
(1,573 |
) |
|
|
(897 |
) |
|
|
— |
|
|
|
(2,470 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
370,000 |
|
|
|
(303,099 |
) |
|
|
(727,266 |
) |
|
|
— |
|
|
|
(660,365 |
) |
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings on long-term debt
|
|
|
1,480,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,480,000 |
|
Borrowings on revolving credit facility
|
|
|
179,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
179,000 |
|
Principal payments on revolving credit facility
|
|
|
(337,000 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(337,000 |
) |
Principal payments on long-term debt
|
|
|
(49,706 |
) |
|
|
(293,000 |
) |
|
|
(3,344 |
) |
|
|
296,109 |
|
|
|
(49,941 |
) |
Repayment of assumed debt
|
|
|
(1,348,389 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,348,389 |
) |
Repayment of long-term debt
|
|
|
(200,594 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(200,594 |
) |
Payment of debt issuance costs
|
|
|
(36,649 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(36,649 |
) |
Issuance of common stock
|
|
|
685,097 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
685,097 |
|
Common stock withheld for minimum statutory taxes, net
|
|
|
(8,846 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(8,846 |
) |
Excess tax benefit from equity awards
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Other
|
|
|
(1,149 |
) |
|
|
(2,688 |
) |
|
|
— |
|
|
|
— |
|
|
|
(3,837 |
) |
Cash (used in) provided by intercompany activity
|
|
|
(707,925 |
) |
|
|
460,196 |
|
|
|
546,947 |
|
|
|
(299,218 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
(346,161 |
) |
|
|
164,508 |
|
|
|
543,603 |
|
|
|
(3,109 |
) |
|
|
358,841 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
— |
|
|
|
— |
|
|
|
(14,106 |
) |
|
|
— |
|
|
|
(14,106 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
— |
|
|
|
13,694 |
|
|
|
32,154 |
|
|
|
— |
|
|
|
45,848 |
|
Cash and cash equivalents at beginning of the period
|
|
|
— |
|
|
|
1,987 |
|
|
|
9,228 |
|
|
|
— |
|
|
|
11,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of the period
|
|
$ |
— |
|
|
$ |
15,681 |
|
|
$ |
41,382 |
|
|
$ |
— |
|
|
$ |
57,063 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acadia Healthcare Company, Inc.
Condensed Consolidating Statement of Cash
Flows
Year Ended December 31, 2015
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
111,476 |
|
|
$ |
138,764 |
|
|
$ |
37,414 |
|
|
$ |
(176,178 |
) |
|
$ |
111,476 |
|
Adjustments to reconcile net income (loss) to net cash (used in)
provided by continuing operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in earnings of subsidiaries
|
|
|
(176,178 |
) |
|
|
— |
|
|
|
— |
|
|
|
176,178 |
|
|
|
— |
|
Depreciation and amortization
|
|
|
— |
|
|
|
41,768 |
|
|
|
21,782 |
|
|
|
— |
|
|
|
63,550 |
|
Amortization of debt issuance costs
|
|
|
7,147 |
|
|
|
— |
|
|
|
(438 |
) |
|
|
— |
|
|
|
6,709 |
|
Equity-based compensation expense
|
|
|
20,472 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
20,472 |
|
Deferred income tax (benefit) expense
|
|
|
617 |
|
|
|
42,246 |
|
|
|
750 |
|
|
|
— |
|
|
|
43,613 |
|
Loss from discontinued operations, net of taxes
|
|
|
— |
|
|
|
(111 |
) |
|
|
— |
|
|
|
— |
|
|
|
(111 |
) |
Debt extinguishment costs
|
|
|
10,818 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10,818 |
|
Loss (gain) on foreign currency derivatives
|
|
|
1,926 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,926 |
|
Other
|
|
|
— |
|
|
|
1,582 |
|
|
|
33 |
|
|
|
— |
|
|
|
1,615 |
|
Change in operating assets and liabilities, net of effect of
acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
— |
|
|
|
(18,632 |
) |
|
|
(6,322 |
) |
|
|
— |
|
|
|
(24,954 |
) |
Other current assets
|
|
|
— |
|
|
|
(1,152 |
) |
|
|
(1,565 |
) |
|
|
— |
|
|
|
(2,717 |
) |
Other assets
|
|
|
(1,100 |
) |
|
|
(8,567 |
) |
|
|
546 |
|
|
|
1,100 |
|
|
|
(8,021 |
) |
Accounts payable and other accrued liabilities
|
|
|
— |
|
|
|
(7,583 |
) |
|
|
14,451 |
|
|
|
— |
|
|
|
6,868 |
|
Accrued salaries and benefits
|
|
|
— |
|
|
|
312 |
|
|
|
1,346 |
|
|
|
— |
|
|
|
1,658 |
|
Other liabilities
|
|
|
— |
|
|
|
9,350 |
|
|
|
(114 |
) |
|
|
— |
|
|
|
9,236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by continuing operating activities
|
|
|
(24,822 |
) |
|
|
197,977 |
|
|
|
67,883 |
|
|
|
1,100 |
|
|
|
242,138 |
|
Net cash provided by discontinued operating activities
|
|
|
— |
|
|
|
(1,735 |
) |
|
|
— |
|
|
|
— |
|
|
|
(1,735 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by operating activities
|
|
|
(24,822 |
) |
|
|
196,242 |
|
|
|
67,883 |
|
|
|
1,100 |
|
|
|
240,403 |
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for acquisitions, net of cash acquired
|
|
|
— |
|
|
|
(254,848 |
) |
|
|
(319,929 |
) |
|
|
— |
|
|
|
(574,777 |
) |
Cash paid for capital expenditures
|
|
|
— |
|
|
|
(172,329 |
) |
|
|
(103,718 |
) |
|
|
— |
|
|
|
(276,047 |
) |
Cash paid for real estate acquisitions
|
|
|
— |
|
|
|
(25,293 |
) |
|
|
(1,329 |
) |
|
|
— |
|
|
|
(26,622 |
) |
Settlement of foreign currency derivatives
|
|
|
— |
|
|
|
(1,926 |
) |
|
|
— |
|
|
|
— |
|
|
|
(1,926 |
) |
Other
|
|
|
— |
|
|
|
(5,099 |
) |
|
|
— |
|
|
|
— |
|
|
|
(5,099 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
— |
|
|
|
(459,495 |
) |
|
|
(424,976 |
) |
|
|
— |
|
|
|
(884,471 |
) |
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings on long-term debt
|
|
|
1,150,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,150,000 |
|
Borrowings on revolving credit facility
|
|
|
468,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
468,000 |
|
Principal payments on revolving credit facility
|
|
|
(310,000 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(310,000 |
) |
Principal payments on long-term debt
|
|
|
(31,965 |
) |
|
|
— |
|
|
|
(1,315 |
) |
|
|
1,315 |
|
|
|
(31,965 |
) |
Repayment of assumed CRC debt
|
|
|
(904,467 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(904,467 |
) |
Repayments of senior notes
|
|
|
(97,500 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(97,500 |
) |
Payment of debt issuance costs
|
|
|
(26,421 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(26,421 |
) |
Payment of premium on senior notes
|
|
|
(7,480 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(7,480 |
) |
Issuance of Common Stock
|
|
|
331,308 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
331,308 |
|
Common stock withheld for minimum statutory taxes, net
|
|
|
(7,762 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(7,762 |
) |
Excess tax benefit from equity awards
|
|
|
309 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
309 |
|
Other
|
|
|
— |
|
|
|
(420 |
) |
|
|
— |
|
|
|
— |
|
|
|
(420 |
) |
Cash provided by (used in) intercompany activity
|
|
|
(539,200 |
) |
|
|
191,334 |
|
|
|
350,281 |
|
|
|
(2,415 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
24,822 |
|
|
|
190,914 |
|
|
|
348,966 |
|
|
|
(1,100 |
) |
|
|
563,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
— |
|
|
|
(2,359 |
) |
|
|
— |
|
|
|
— |
|
|
|
(2,359 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents
|
|
|
— |
|
|
|
(74,698 |
) |
|
|
(8,127 |
) |
|
|
— |
|
|
|
(82,825 |
) |
Cash and cash equivalents at beginning of the period
|
|
|
— |
|
|
|
76,685 |
|
|
|
17,355 |
|
|
|
— |
|
|
|
94,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of the period
|
|
$ |
— |
|
|
$ |
1,987 |
|
|
$ |
9,228 |
|
|
$ |
— |
|
|
$ |
11,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acadia Healthcare Company, Inc.
Condensed Consolidating Statement of Cash
Flows
Year Ended December 31, 2014
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
Combined
Subsidiary
Guarantors |
|
|
Combined
Non-
Guarantors |
|
|
Consolidating
Adjustments |
|
|
Total
Consolidated
Amounts |
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
83,040 |
|
|
$ |
83,824 |
|
|
$ |
13,590 |
|
|
$ |
(97,414 |
) |
|
$ |
83,040 |
|
Adjustments to reconcile net income (loss) to net cash (used in)
provided by continuing operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in earnings of subsidiaries
|
|
|
(97,414 |
) |
|
|
— |
|
|
|
— |
|
|
|
97,414 |
|
|
|
— |
|
Depreciation and amortization
|
|
|
— |
|
|
|
22,990 |
|
|
|
9,677 |
|
|
|
— |
|
|
|
32,667 |
|
Amortization of debt issuance costs
|
|
|
2,748 |
|
|
|
— |
|
|
|
450 |
|
|
|
— |
|
|
|
3,198 |
|
Equity-based compensation expense
|
|
|
10,058 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10,058 |
|
Deferred income tax (benefit) expense
|
|
|
(1,969 |
) |
|
|
5,231 |
|
|
|
3,953 |
|
|
|
— |
|
|
|
7,215 |
|
Loss from discontinued operations, net of taxes
|
|
|
— |
|
|
|
192 |
|
|
|
— |
|
|
|
— |
|
|
|
192 |
|
Gain on foreign currency derivatives
|
|
|
(15,262 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(15,262 |
) |
Other
|
|
|
— |
|
|
|
449 |
|
|
|
39 |
|
|
|
— |
|
|
|
488 |
|
Change in operating assets and liabilities, net of effect of
acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
— |
|
|
|
(13,636 |
) |
|
|
(1,474 |
) |
|
|
— |
|
|
|
(15,110 |
) |
Other current assets
|
|
|
— |
|
|
|
(2,205 |
) |
|
|
194 |
|
|
|
— |
|
|
|
(2,011 |
) |
Other assets
|
|
|
(1,151 |
) |
|
|
(6,910 |
) |
|
|
397 |
|
|
|
1,151 |
|
|
|
(6,513 |
) |
Accounts payable and other accrued liabilities
|
|
|
— |
|
|
|
(5,559 |
) |
|
|
8,352 |
|
|
|
— |
|
|
|
2,793 |
|
Accrued salaries and benefits
|
|
|
— |
|
|
|
11,035 |
|
|
|
945 |
|
|
|
— |
|
|
|
11,980 |
|
Other liabilities
|
|
|
— |
|
|
|
1,769 |
|
|
|
980 |
|
|
|
— |
|
|
|
2,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by continuing operating activities
|
|
|
(19,950 |
) |
|
|
97,180 |
|
|
|
37,103 |
|
|
|
1,151 |
|
|
|
115,484 |
|
Net cash used in discontinued operating activities
|
|
|
— |
|
|
|
(198 |
) |
|
|
— |
|
|
|
— |
|
|
|
(198 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by operating activities
|
|
|
(19,950 |
) |
|
|
96,982 |
|
|
|
37,103 |
|
|
|
1,151 |
|
|
|
115,286 |
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for acquisitions, net of cash acquired
|
|
|
— |
|
|
|
(723,064 |
) |
|
|
(15,638 |
) |
|
|
— |
|
|
|
(738,702 |
) |
Cash paid for capital expenditures
|
|
|
— |
|
|
|
(83,864 |
) |
|
|
(29,380 |
) |
|
|
— |
|
|
|
(113,244 |
) |
Cash paid for real estate acquisitions
|
|
|
— |
|
|
|
(23,177 |
) |
|
|
— |
|
|
|
— |
|
|
|
(23,177 |
) |
Settlement of foreign currency derivatives
|
|
|
15,262 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
15,262 |
|
Other
|
|
|
— |
|
|
|
(913 |
) |
|
|
— |
|
|
|
— |
|
|
|
(913 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
15,262 |
|
|
|
(831,018 |
) |
|
|
(45,018 |
) |
|
|
— |
|
|
|
(860,774 |
) |
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings on long-term debt
|
|
|
542,500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
542,500 |
|
Borrowings on revolving credit facility
|
|
|
230,500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
230,500 |
|
Principal payments on revolving credit facility
|
|
|
(284,000 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(284,000 |
) |
Principal payments on long-term debt
|
|
|
(7,500 |
) |
|
|
— |
|
|
|
(1,346 |
) |
|
|
1,151 |
|
|
|
(7,695 |
) |
Payment of debt issuance costs
|
|
|
(12,993 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(12,993 |
) |
Issuance of common stock, net
|
|
|
374,431 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
374,431 |
|
Common stock withheld for minimum statutory taxes, net
|
|
|
(4,099 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,099 |
) |
Excess tax benefit from equity awards
|
|
|
4,617 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,617 |
|
Cash paid for contingent consideration
|
|
|
— |
|
|
|
(5,000 |
) |
|
|
— |
|
|
|
— |
|
|
|
(5,000 |
) |
Other
|
|
|
— |
|
|
|
(289 |
) |
|
|
— |
|
|
|
— |
|
|
|
(289 |
) |
Cash (used in) provided by intercompany activity
|
|
|
(838,768 |
) |
|
|
816,010 |
|
|
|
23,135 |
|
|
|
(377 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
4,688 |
|
|
|
810,721 |
|
|
|
21,789 |
|
|
|
774 |
|
|
|
837,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
— |
|
|
|
— |
|
|
|
(3,013 |
) |
|
|
— |
|
|
|
(3,013 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
— |
|
|
|
76,685 |
|
|
|
10,861 |
|
|
|
1,925 |
|
|
|
89,471 |
|
Cash and cash equivalents at beginning of the period
|
|
|
— |
|
|
|
— |
|
|
|
6,494 |
|
|
|
(1,925 |
) |
|
|
4,569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of the period
|
|
$ |
— |
|
|
$ |
76,685 |
|
|
$ |
17,355 |
|
|
$ |
— |
|
|
$ |
94,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|